US FDA approves Novavax’s BLA for Covid-19 vaccine, Nuvaxovid
Novavax, Inc. announced that the US Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for Nuvaxovid for active immunization to prevent coronavirus disease 2019 (Covid-19) caused by severe acute respiratory syndrome …